Natco to enter bio-generics; signs up with Mabxience
Hindu Business Line
Three of these products—Tastuzumab, Bevacizumab and Rituximab — belong to the oncology segment, while Etanercept is for auto-immune disorders. Biogenerics are biopharmaceutical products developed using biological processes. The Hyderabad-based Natco ...
Natco Pharmaceuticals inks pact with Swiss firm Chemo Sa Lugano for purchase ...Economic Times
Natco Pharma inks pact with
Natco Pharma Signs Pact With MabxienceRTT News

all 20 news articles »